{"nct_id":"NCT04086472","title":"Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005)","status":"COMPLETED","status_verified_date":"2022-08","start_date":"2019-10-28","start_date_type":"ACTUAL","primary_completion_date":"2020-03-22","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}